Abstract
In patients with colorectal cancer, resection of liver-limited metastatic disease provides the only chance of cure. A recent study showed that the addition of cetuximab to conventional chemotherapy significantly increased the response rate and the rate of liver metastases resection in patients with colorectal cancer, providing another chance to cure patients with initially liver-limited unresectable disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
